Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta ‐analysis

ConclusionElevated troponin levels predict LV dysfunction in patients receiving cancer therapy. Assessment of troponin levels may qualify as a screening test to identify patients who require referral to cardio ‐oncology units and benefit from preventive strategies. Further evidence is required for both biomarkers.

Source: European Journal of Heart Failure - November 11, 2019 Category: Cardiology Authors: Lars Michel, Raluca I. Mincu, Amir A. Mahabadi, Stephan Settelmeier, Fadi Al ‐Rashid, Tienush Rassaf, Matthias Totzeck Tags: Research Article Source Type: research